T790M mutation and c-MET amplification might be correlated to TTP of EGFR-TKI in NSCLC

摘要: 8107 Background: In current knowledge about 50% of non-small cell lung cancer resistance to TKI is due the occurrence a secondary mutation in exon 20 EGFR (T790M) and 20% c-MET amplific...